Amlodipine Besylate Tablet
Product Images NDC 70518-2981

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 70518-2981). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Amlodipine Besylate 5 mg tablet label with a quantity of 30 tablets. The label includes the NDC number 70518-2981-00, manufacturer Ascend Labs LLC in Montvale, NJ, and instructions to see package insert for directions. It notes repackaging by RemedyRepack Inc., Indiana, PA. The label also warns to keep medication out of reach of children and includes storage temperature guidelines.*

FDA Label Image

Mm2 (Amlodipine Besylate 5mg 70518 2981 01)

Amlodipine Besylate 5 mg tablet label displaying the product name and strength prominently with a quantity of 90 tablets. The label indicates the product is prescription-only (RX ONLY) and includes manufacturer details: repackaged by RemedyRepack Inc. with original manufacturer Ascend Labs, LLC. Additional information includes storage directions and a QR code.*

FDA Label Image

Amlodipine Besylate 5mg 70518 2981 02

Amlodipine Besylate 5 mg tablet label showing dosage strength and quantity of 30 tablets. The label identifies the product as repackaged by RemedyRepack Inc. and includes storage instructions, a QR code, and the source manufacturer as Ascend Labs, LLC. It is marked RX only for oral use.*

FDA Label Image

Amlodipine Besylate 5mg 70518 2981 03

Amlodipine Besylate 5 mg tablet label showing quantity of 28 tablets. The label indicates oral dosage form and is repackaged by RemedyRepack Inc. It includes manufacturer information (Ascend Labs, LLC, Montvale, NJ), storage instructions, and a warning to keep medication out of reach of children. The label features a QR code and source NDC.*

FDA Label Image

Figure 2 (Amlodipine Fig)

A horizontal forest plot displaying hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across multiple patient subgroups including age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent status. The plot indicates the relative effects within these categories among 1,818 patients overall.*

FDA Label Image

Figure 1 (Amlodipine Gra)

A Kaplan-Meier curve showing event rate over 24 months comparing Amlodipine and Placebo groups. The y-axis represents event rate, and the x-axis shows time in months. The chart includes a p-value of 0.003, a hazard ratio of 0.691, and a 95% confidence interval (0.54, 0.88). The number of subjects at risk is displayed along the x-axis.*

FDA Label Image

Amlodipine-str-2 (Amlodipine Str 2)

Chemical structure diagram of amlodipine besylate, showing its molecular framework including rings, substituents, and functional groups. The structure highlights atoms such as chlorine, nitrogen, oxygen, and carbon along with the benzenesulfonate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.